Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee

NCT00878501 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

241

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated after the planned interim analysis.

Conditions

Pain

Interventions

DRUG: AZD1386
DRUG: AZD1386
DRUG: Placebo

Sponsor

AstraZeneca